Loading...
XTSX
WBE
Market cap4mUSD
Nov 25, Last price  
0.18CAD
Name

Westbond Enterprises Corp

Chart & Performance

D1W1MN
XTSX:WBE chart
P/E
P/S
0.66
EPS
Div Yield, %
Shrs. gr., 5y
0.72%
Rev. gr., 5y
-3.17%
Revenues
10m
+4.91%
6,259,4266,303,3865,739,4366,003,3086,198,3266,085,3506,078,4646,324,4796,599,4407,349,4167,788,0498,969,3719,829,02511,363,16211,363,16211,667,89213,979,80811,089,7939,219,9489,673,000
Net income
-52k
L-75.14%
114,69795,28495,385163,608104,05429,015124,135120,66246,655-431,22352,878161,080298,088421,264421,264591,0162,642,997574,550-210,683-52,380
CFO
1m
+136.28%
428,109234,899512,241327,300433,208270,597183,390290,365486,321797,072515,956987,4641,294,3891,523,7921,523,7921,676,0784,975,6341,933,280492,8141,164,441
Dividend
Dec 02, 20220.005 CAD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

WestBond Enterprises Corporation, together with its subsidiary WestBond Industries Inc., manufactures and sells disposable paper products for medical, hygienic, and industrial uses in Canada and the United States. The company offers personal hygiene paper products, such as roll and folded hand towels, jumbo roll and conventional bathroom tissue, coreless tissue, center feed towels, and air-laid center feed towels; hospitality and tabletop paper products comprising air-laid napkins, guest towels, air-laid kitchen roll towels, and disposable bar towels; and clinical products, including sheets, examination table papers, waterproof sheets, pillowcases, examination drapes and gowns, and ultrasound towels and wipers. It also provides long-term care products, including fold and roll air laid patient wipes and waterproof underlays; disinfectant wipes and sprays; and airlaid rolls for converters. It sells its products primarily to medical and industrial distributors, as well as to end-users on a direct basis. WestBond Enterprises Corporation is headquartered in Delta, Canada.
IPO date
Feb 11, 1992
Employees
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT